R

Raaj Medisafe India Limited

RAAJMEDI
Market snapshot · 2026-08-11 08:40 UTC

67.20

₹0.00 (+0.00%)

MARKET CAP

₹88.82 Cr

STOCK P/E

61.1x

52W HIGH

₹96.00

52W LOW

₹64.08

BOOK VALUE

₹28.40

EPS

₹1.10

ROE

4.91%

SECTOR

Health Care

DEBT/EQUITY

138.36

VOLUME

200

P/B RATIO

2.37x

PEG RATIO

Sector

Health Care

Themes

Health Care Equipment & Supplies
₹96.00₹88.21₹80.43₹72.64₹64.85VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 10.4% below historical median. Valuation is stable — currently in the strongly undervalued zone (z-score: -0.33). Confidence: 73%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Strongly Undervalued

5Y Average

53.78

Current

61.09

Overvalued

81.53

Undervalued

58.27

EV/EBITDA
Fair

5Y Average

12.14

Current

13.79

Overvalued

16.14

Undervalued

7.71

P/S
Overvalued

5Y Average

0.97

Current

1.11

Overvalued

1.12

Undervalued

0.83

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹25 CrMar 2026

Latest net profit

₹-3.23 CrMar 2026

Latest EPS

₹-1.97Mar 2026

Net margin

10.8%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.0%5.0%10.0%15.0%20.0%-9.00 Cr0.00 Cr9.00 Cr18 Cr27 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr7.00 Cr14 Cr21 Cr28 Cr₹-2₹0₹2₹4₹6
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherNet Profit-9.00 Cr0.00 Cr9.00 Cr18 Cr27 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-45 Cr0.00 Cr45 Cr90 Cr135 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +9.6610.5211.2010.1711.3610.9110.9114.5924.4015.8318.4020.7125.08
Expenses +8.179.319.638.659.049.189.1812.3721.2913.2115.6517.0222.37
Operating Profit1.491.211.571.522.321.731.732.223.112.622.753.692.71
OPM %15.42%11.50%14.02%14.95%20.42%15.86%15.86%15.22%12.75%16.55%14.95%17.82%10.81%
Other Income +0.010.010.010.000.040.000.00-0.010.110.010.230.040.28
Interest0.310.390.330.370.470.360.360.520.680.680.821.381.08
Depreciation0.190.200.200.210.230.230.230.400.440.490.430.500.63
Profit before tax1.000.631.050.941.661.141.141.292.101.461.731.851.28
Tax %44.00%0.00%0.00%0.00%57.83%15.79%15.79%19.38%-65.24%0.00%0.00%-2.70%353.12%
Net Profit +0.560.631.060.940.700.970.971.033.481.461.731.89-3.23
EPS in Rs0.510.580.970.860.640.730.730.782.631.111.321.44-1.97
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +73.45%73.80%73.80%73.80%59.08%
Public +26.55%26.20%26.20%26.19%40.92%
Others0.01%
Jun 2026
Promoters +
Public +

Events Timeline

Board Meeting Intimation for Intimation Of Board Meeting

Aug 04, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 10, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Cessation

Jul 10, 2026PDFCompany Reports Open

Closure of Trading Window

Jun 19, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Newspaper Publication

Jun 01, 2026PDFCompany Reports Open